Fureasu Co., Ltd. (7062) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Fureasu Co., Ltd. (7062:JPX), powered by AI.
- Current Price
- ¥799
- Sector
- Consumer Cyclical
What is the Fureasu Co., Ltd. stock price forecast?
Fureasu Co., Ltd. is currently trading at ¥799. View real-time AI analysis on Alpha Lenz.
What is Fureasu Co., Ltd. insider trading activity?
View the latest insider trading data for Fureasu Co., Ltd. on Alpha Lenz.
What is Fureasu Co., Ltd.'s P/E ratio?
View Fureasu Co., Ltd.'s valuation metrics on Alpha Lenz.
Fureasu Co., Ltd.
JPX · 7062“Fureasu Co., Ltd.'s ROE is 27.3%. Explore profitability and growth together.”
Ask for details →Company Overview
Fureasu Co., Ltd. is a prominent player in the nursing care and welfare services industry in Japan. The company specializes in providing comprehensive human resources services, focusing on staffing and temporary employment for nursing care facilities and hospitals. Fureasu Co., Ltd. is dedicated to supporting the healthcare industry through the recruitment and placement of care workers, registered nurses, and other healthcare professionals. In addition to staffing solutions, the company is involved in training and educational services, enhancing the skills and qualifications of workers in the healthcare sector. Operating in this essential field, Fureasu Co., Ltd. plays a critical role in addressing the staffing needs of Japan's growing elderly population and contributes to the overall improvement and accessibility of health and welfare services.
Company Statistics
FY 2026Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“Fureasu Co., Ltd.'s ROE is 27.3%. Explore profitability and growth together.”
Ask for details →Frequently Asked Questions
Fureasu Co., Ltd. (ticker: 7062) is a company listed on JPX in the Consumer Cyclical sector (Personal Services). It has approximately 801 employees.
The current price is 799 with a P/E ratio of -x and P/B of -x.
ROE is 27.30% and operating margin is 3.84%. Annual revenue is $7.6B.